Inhibiting somatostatin may prevent dangerous blood glucose drops in type 1 diabetes

Inhibiting the hormone somatostatin may be a new treatment strategy to prevent dangerous blood glucose drops in type 1 diabetes. This has been shown by a study conducted by the University of Gothenburg and other institutions. The proposed strategy is said to have the potential to save lives.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup